Sangamo Therapeutics
(NASDAQ) SGMO
Sangamo Therapeutics Financials at a Glance
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$34.56M
Net Income (TTM)
-$123.33M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Estimated Earnings Date
Aug 6, 2026
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Estimated Earnings Date
Aug 6, 2026
SGMO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sangamo Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
142
CEO
Alexander D. Macrae, PhD
Website
www.sangamo.comHeadquarters
Richmond, CA 94804, US
SGMO Financials
Key Financial Metrics (TTM)
Gross Margin
N/A
Operating Margin
N/A
Net Income Margin
N/A
Return on Equity
N/A
Return on Capital
-862.17%
Return on Assets
N/A
Earnings Yield
N/A
Payout Ratio
N/A
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$34.56M
Operating Income
-$110.32M
EBITDA
-$117.46M
Operating Cash Flow
-$90.34M
Capital Expenditure
-$115.00K
Free Cash Flow
-$90.46M
Cash & ST Invst.
$27.59M
Total Debt
$19.33M
Sangamo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.44M
-77.6%
Gross Profit
$1.44M
-77.6%
Gross Margin
100.00%
N/A
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
127
N/A
Net Income
-$31.00M
-1.3%
EBITDA
-$30.12M
-5.5%
Quarterly Fundamentals
Total Cash
$27.59M
+9.6%
Total Debt
$19.33M
-22.3%
Accounts Receivable
$6.36M
+38.1%
Inventory
$0.00
N/A
Long Term Debt
$19.33M
-22.3%
Short Term Debt
$0.00
N/A
Return on Assets
N/A
N/A
Return on Invested Capital
N/A
N/A
Free Cash Flow
-$19.30M
+26.2%
Operating Cash Flow
-$19.28M
+26.3%